Boothbay Fund Management »

Tango Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.5M 957k 8.86

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Tango Therapeutics

Farallon Capital Management
TCG Crossover Management
Woodline Partners
Boxer Capital Management
BlackRock
Siren
Trv Gp Iv
Vanguard Group
State Street Corporation
Nextech Invest
Goldman Sachs Group
Gilead Sciences
Logos Global Management
Bellevue Group
Caligan Partners

View all funds holding Tango Therapeutics